Recommendations for the development of new anticoagulant drugs for pediatric use: communication from the SSC of the ISTH

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|3|481-484

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.3, 2015-03, pp. : 481-484

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 16, Iss. 2, 2018-02 ,pp. : 405-408

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recommendations for the use of the non‐obese diabetic/severe combined immunodeficiency mouse model in autoimmune and drug‐induced thrombocytopenia: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 872-875

John Wiley & Sons Inc

Access to resources Recommend Favorite

Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 876-879

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recommendations for the assessment of non‐extremity venous thromboembolism outcomes: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 3, 2015-03 ,pp. : 477-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recommendations for standardization of laboratory testing for drug‐induced immune thrombocytopenia: communication from the SSC of the ISTH

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 4, 2015-04 ,pp. : 676-678

John Wiley & Sons Inc

Access to resources Recommend Favorite